Nucleotide sequences coding for the dapc gene and process for the production of l-lysine
CA 2339307 A1 · Owner: Kalinowski, Jorn · Inventors: Kalinowski, Jorn; Pfefferle, Walter; Puhler, Alfred
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an isolated polynucleotide from coryneform bacteria containing at least one polynucleotide sequence selected from the group consisting of a) polynucleotide which is at least 70% identical to a polynucleotide which codes for a polypeptide containing the amino acid sequence according to SEQ ID no. 2, b) polynucleotide which codes for a polypeptide which contains an amino acid sequence which is at least 70% identical to the amino acid sequence of SEQ ID no. 2 c) polynucleotide which is complementary to the polynucleotides of a) or b), and, d) polynucleotide containing at least 15 successive nucleotides of the polynucleotide sequences of a) b), or c), and to a process …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 21, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.